Aug 24 (Reuters) - Qlife Holding AB QLIFE.ST :
* QLIFE CARRIES OUT A RIGHTS ISSUE OF UNITS OF APPROXIMATELY
SEK
76 MILLION AND BRINGS FORWARD THE PUBLICATION OF THE INTERIM
REPORT FOR THE FIRST HALF OF 2022
* RIGHTS ISSUE MAINLY INTENDS TO FINANCE APPROVAL OF A CRP
TEST
FOR SELF-TEST USE IN EUROPEAN MARKETS AS WELL AS COMPLETION AND
FILING OF CLINICAL STUDIES FOR CE APPROVAL OF A PHE TEST FOR
SELF-TEST USE
* MEMBERS OF COMPANY'S BOARD OF DIRECTORS AND SENIOR
EXECUTIVES
HAVE EXPRESSED THEIR INTENT TO SUBSCRIBE FOR A TOTAL OF
APPROXIMATELY SEK 1.3 MILLION
* HAS RECEIVED GUARANTEE UNDERTAKINGS OF APPROXIMATELY SEK
51.7
MILLION, CORRESPONDING TO A TOTAL OF APPROXIMATELY 70 PERCENT OF
RIGHTS ISSUE
* UPON FULL SUBSCRIPTION IN RIGHTS ISSUE, QLIFE WILL
INITIALLY
RECEIVE APPROXIMATELY SEK 76 MILLION BEFORE ISSUE COSTS
* UPON FULL EXERCISE OF ALL WARRANTS, QLIFE WILL RECEIVE
ADDITIONAL PROCEEDS OF A MAXIMUM OF APPROXIMATELY SEK 108
MILLION BEFORE ISSUE COSTS
* RIGHTS ISSUE IS SUBJECT TO APPROVAL BY EXTRAORDINARY
GENERAL
MEETING ON 27 SEPTEMBER 2022
Source text for Eikon: ID:nWkr4vsp1C
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))